+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Pretreatment prognostic factors for survival in non-small-cell lung cancer: A multivariate analysis of 229 patients



Pretreatment prognostic factors for survival in non-small-cell lung cancer: A multivariate analysis of 229 patients



Onkologie 21(3): 204-210



Background: In order to identify the clinical and biochemical important prognostic factors in patients with inoperable non-small-cell lung cancer (NSCLC) receiving chemotherapy or radiochemotherapy, univariate and multivariate regression analyses were performed. Furthermore, we formulated a score for survival that allowed to divide patients into three prognostic groups. Material and Methods: 229 previously untreated patients who had received chemotherapy or combined radiochemotherapy at the Thoraxklinik Heidelberg-Rohrbach between January 1987 and December 1990 were eligible for the analysis. We prospectively evaluated data on 30 pretreatment factors (7 clinical and 23 laboratory variables) and analyzed them by univariate and multivariate methods. Results: The estimated overall median survival time was 161 days. The univariate analyses revealed that 20 parameters were statistically significant for survival. Cox's multivariate regression analysis indicated that female sex (p = 0.012), a sodium level > 137.5 mmol/l (p < 0.001) and a low stage of disease (TNM stages I, II and IIIA) (p < 0.001) contributed independently to survival. Based on these three independent predictive factors, a prognostic factor risk index was created for each patient to divide the patients into three prognostic groups (good, average, poor). The median survival time within these groups was 409 days vs. 160 days vs. 91 days (p < 0.001). Conclusions: Our findings confirm the important role of well-known independent prognostic factors for survival in NSCLC patients, such as TNM and sex. For sodium there are no comparable analyses at present, and therefore further investigation of this factor is needed. The proposed prognostic index appears to be a feasible tool to develop new treatment strategies in NSCLC.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 009238833

Download citation: RISBibTeXText

DOI: 10.1159/000026816


Related references

Prognostic factors for survival in inoperable non-small-cell lung cancer: A multivariate regression analysis of 456 patients with radiation therapy. Onkologie 20(2): 126-131, 1997

Pretreatment prognostic factors for survival in small-cell lung cancer: a new prognostic index and validation of three known prognostic indices on 341 patients. Annals of Oncology 8(6): 547-553, 1997

Is a patient's self-reported health-related quality of life a prognostic factor for survival in non-small-cell lung cancer patients? A multivariate analysis of prognostic factors of EORTC study 08975. Annals of Oncology 17(11): 1698-1704, 2006

Prognostic factors with a multivariate analysis for survival pfas in advanced non small cell lung cancer overview of experience of the european lung cancer working party. Proceedings of the American Association for Cancer Research Annual Meeting 32: 190, 1991

Multivariate analysis of prognostic factors in patients with small cell lung cancer. Zhongguo Fei Ai Za Zhi 9(6): 525-529, 2006

Prognostic factors for survival in advanced non-small-cell lung cancer: univariate and multivariate analyses including recursive partitioning and amalgamation algorithms in 1,052 patients. The European Lung Cancer Working Party. Journal of Clinical Oncology 13(5): 1221-1230, 1995

Multivariate analysis of prognostic factors in the eldly patients with small cell lung cancer: a study of 160 patients. Zhongguo Fei Ai Za Zhi 17(1): 15-23, 2014

Pretreatment clinical prognostic factors influencing survival in patients with stage III non-small cell lung cancer treated with hyperfractionated radiation therapy with or without concurrent chemotherapy. EJC Suppl.s 1(5): S237, 2003

Pretreatment Glasgow prognostic score and prognostic nutritional index predict overall survival of patients with advanced small cell lung cancer. Lung Cancer 8: 249-257, 2017

Pretreatment quality of life and functional status assessment significantly predict survival of elderly patients with advanced non-small-cell lung cancer receiving chemotherapy: a prognostic analysis of the multicenter Italian lung cancer in the elderly study. Journal of Clinical Oncology 23(28): 6865-6872, 2005

Analysis of prognostic factors for long term survival in patients with small cell lung cancer. Pneumonologia i Alergologia Polska 62(5-6): 233-238, 1994

Preliminary Analysis of Pretreatment Diffusion-Weighted MRI and (18)F-FDG PET/CT as Prognostic Factors in Patients With Non-Small Cell Lung Cancer Receiving Stereotactic Body Radiation Therapy. Practical Radiation Oncology 3(2 Suppl 1): S13, 2014

Five-year survival analysis and prognostic factors in patients operated on for non-small cell lung cancer with N2 disease. Journal of Thoracic Disease 10(6): 3180-3186, 2018

Analysis of prognostic factors in 766 patients with small cell lung cancer (SCLC): the role of sex as a predictor for survival. British Journal of Cancer 63(6): 986-992, 1991

Prognostic factors in patients with inoperable non-small cell lung cancer--an analysis of long-term survival patients. Gan to Kagaku Ryoho. Cancer and ChemoTherapy 33(11): 1595-1602, 2006